{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:51:43Z","timestamp":1793235103993,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX09101002-001-006"],"award-info":[{"award-number":["2017ZX09101002-001-006"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX09101002-001-001-3"],"award-info":[{"award-number":["2017ZX09101002-001-001-3"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebral malaria (CM) is a life-threatening neurological complication caused by Plasmodium falciparum. About 627,000 patients died of malaria\u00a0in 2020. Currently, artemisinin and its derivatives are the front-line drugs used for the treatment of cerebral malaria. However, they cannot target the brain, which decreases their effectiveness. Therefore, increasing their ability to target the brain by the nano-delivery system with brain-targeted materials is of great significance for enhancing the effects of antimalarials and reducing CM mortality. This study used glucose transporter 1 (GLUT1) on the blood\u2013brain barrier as a target for a synthesized cholesterol-undecanoic acid\u2013glucose conjugate. The molecular dynamics simulation found that the structural fragment of glucose in the conjugate faced the outside the phospholipid bilayers, which was conducive to the recognition of brain-targeted liposomes by GLUT1. The fluorescence intensity of the brain-targeted liposomes (na-ATS\/TMP@lipoBX) in the mouse brain was significantly higher than that of the non-targeted liposomes (na-ATS\/TMP@lipo) in vivo (P\u2009&lt;\u20090.001) after intranasal administration. The infection and recurrence rate of the mice receiving na-ATS\/TMP@lipoBX treatment were significantly decreased, which had more advantages than those of other administration groups. The analysis of pharmacokinetic data showed that na-ATS\/TMP@lipoBX could enter the brain in both systemic circulation and nasal-brain pathway to treat malaria. Taken together, these results in this study\u00a0provide\u00a0a new approach to the treatment of cerebral malaria.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-022-01493-8","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T10:02:41Z","timestamp":1657101761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria"],"prefix":"10.1186","volume":"20","author":[{"given":"Ya","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-2687","authenticated-orcid":false,"given":"Shuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"issue":"4","key":"1493_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","volume":"68","author":"R Idro","year":"2010","unstructured":"Idro R, Marsh K, John CC, et al. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010;68(4):267\u201374.","journal-title":"Pediatr Res"},{"key":"1493_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainresbull.2019.01.010","volume":"145","author":"AL Luzolo","year":"2019","unstructured":"Luzolo AL, Ngoyi DM. Cerebral malaria. Brain Res Bull. 2019;145:53\u20138.","journal-title":"Brain Res Bull"},{"key":"1493_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.11604\/pamj.2017.27.224.11026","volume":"27","author":"CN Nanfack","year":"2017","unstructured":"Nanfack CN, Bilong Y, Kagmeni G, et al. Malarial retinopathy in adult: a case report. Pan Afr Med J. 2017;27:224.","journal-title":"Pan Afr Med J"},{"key":"1493_CR4","unstructured":"Organization World Health, World Malaria Report 2017 2017."},{"issue":"7","key":"1493_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.pt.2019.04.010","volume":"35","author":"G Nishanth","year":"2019","unstructured":"Nishanth G. Schl\u00fcter D, blood-brain barrier in cerebral malaria: pathogenesis and therapeutic intervention. J Trends in Parasitology. 2019;35(7):516\u201328.","journal-title":"J Trends in Parasitology"},{"issue":"1","key":"1493_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12936-018-2195-7","volume":"17","author":"R Varo","year":"2018","unstructured":"Varo R, Crowley VM, Sitoe A, et al. Adjunctive therapy for severe malaria: a review and critical appraisal. Malar J. 2018;17(1):47.","journal-title":"Malar J"},{"issue":"2","key":"1493_CR7","first-page":"208","volume":"55","author":"JX Hui","year":"2020","unstructured":"Hui JX, Yuan ZZ, Hui L, et al. Current advances in research on adjuvant therapy for cerebral malaria. Acta Pharmaceutica Sinica. 2020;55(2):208\u201317.","journal-title":"Acta Pharmaceutica Sinica."},{"issue":"2\u20133","key":"1493_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0163-7258(01)00140-1","volume":"90","author":"GA Balint","year":"2001","unstructured":"Balint GA. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol Ther. 2001;90(2\u20133):261\u20135.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"1493_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm.2471","volume":"17","author":"Y Tu","year":"2011","unstructured":"Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17(10):1217\u201320.","journal-title":"Nat Med"},{"issue":"35","key":"1493_CR10","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1002\/anie.201601967","volume":"55","author":"Y Tu","year":"2016","unstructured":"Tu Y. Artemisinin-a gift from traditional chinese medicine to the world (Nobel Lecture). Angew Chem Int Ed Engl. 2016;55(35):10210\u201326.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"9","key":"1493_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s40265-018-0911-9","volume":"78","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Phyo AP. Drugs in development for malaria. Drugs. 2018;78(9):861\u201379.","journal-title":"Drugs"},{"issue":"2","key":"1493_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.medmal.2019.06.002","volume":"50","author":"M Thellier","year":"2020","unstructured":"Thellier M, Simard F, Musset L, et al. Changes in malaria epidemiology in France and worldwide, 2000\u20132015. J M\u00e9d Et Maladies Infect. 2020;50(2):99\u2013112.","journal-title":"J M\u00e9d Et Maladies Infect"},{"issue":"10267","key":"1493_CR13","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/S0140-6736(20)32677-5","volume":"396","author":"R Van Der Pluijm","year":"2021","unstructured":"Van Der Pluijm R, Aung PP, Lek D, et al. Triple artemisinin-based combination therapies for malaria: proceed with caution. J Lancet. 2021;396(10267):1976\u20137.","journal-title":"J Lancet"},{"key":"1493_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06018-6","author":"W Shibeshi","year":"2021","unstructured":"Shibeshi W, Alemkere G, Mulu A, et al. Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis. J BMC Infect Dis. 2021. https:\/\/doi.org\/10.1186\/s12879-021-06018-6.","journal-title":"J BMC Infect Dis"},{"issue":"2","key":"1493_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.actatropica.2008.02.001","volume":"106","author":"AL Bienvenu","year":"2008","unstructured":"Bienvenu AL, Ferrandiz J, Kaiser K, et al. Artesunate-erythropoietin combination for murine cerebral malaria treatment. J Acta Tropica. 2008;106(2):104\u20138.","journal-title":"J Acta Tropica"},{"issue":"4","key":"1493_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1128\/IAI.01404-15","volume":"84","author":"Carolina Ana; Conrado Kayano Joo; Marcele Dos-Santos","year":"2016","unstructured":"Carolina Ana; Conrado Kayano Joo; Marcele Dos-Santos. Pathophysiological mechanisms in gaseous therapies for severe malaria. J Infection Immunity. 2016;84(4):874\u201382.","journal-title":"J Infection Immunity"},{"issue":"3","key":"1493_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36(3):437\u201349.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1493_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.15171\/bi.2016.30","volume":"6","author":"J Barar","year":"2016","unstructured":"Barar J, Rafi MA, Pourseif MM, et al. Blood-brain barrier transport machineries and targeted therapy of brain diseases. Bioimpacts. 2016;6(4):225\u201348.","journal-title":"Bioimpacts"},{"issue":"2","key":"1493_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","volume":"54","author":"SG Patching","year":"2017","unstructured":"Patching SG. Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery. Mol Neurobiol. 2017;54(2):1046\u201377.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1493_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.brainresrev.2005.03.002","volume":"49","author":"AA Qutub","year":"2005","unstructured":"Qutub AA, Hunt CA. Glucose transport to the brain: a systems model. Brain Res Brain Res Rev. 2005;49(3):595\u2013617.","journal-title":"Brain Res Brain Res Rev"},{"issue":"2","key":"1493_CR21","first-page":"1","volume":"7","author":"R Weber Christopher","year":"2012","unstructured":"Weber Christopher R, Carolina B-A, Christian C-C, et al. Glucose transporter 1 and monocarboxylate transporters 1, 2, and 4 localization within the glial cells of shark blood-brain-barriers. PLoS ONE. 2012;7(2):1\u201318.","journal-title":"PLoS ONE"},{"key":"1493_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115852","volume":"29","author":"Q Liu","year":"2021","unstructured":"Liu Q, Zhou L, Lu R, et al. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma. Bioorg Med Chem. 2021;29: 115852.","journal-title":"Bioorg Med Chem"},{"key":"1493_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201701921","author":"YH Tsou","year":"2017","unstructured":"Tsou YH, Zhang XQ, Zhu H, et al. Drug delivery to the brain across the blood-brain barrier using nanomaterials. Small. 2017. https:\/\/doi.org\/10.1002\/smll.201701921.","journal-title":"Small"},{"issue":"2","key":"1493_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1021\/acs.nanolett.5b03854","volume":"16","author":"X Liang","year":"2016","unstructured":"Liang X, Wang H, Grice JE, et al. Physiologically based pharmacokinetic model for long-circulating inorganic nanoparticles. J Nano Lett. 2016;16(2):939\u201345.","journal-title":"J Nano Lett"},{"key":"1493_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100972","author":"H Huang","year":"2020","unstructured":"Huang H, Wei F, Yu C, et al. Inorganic nanoparticles in clinical trials and translations. J Nano Today. 2020. https:\/\/doi.org\/10.1016\/j.nantod.2020.100972.","journal-title":"J Nano Today"},{"key":"1493_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202008171","author":"Q Liu","year":"2020","unstructured":"Liu Q, Kim YJ, Im GB, et al. Inorganic nanoparticles applied as functional therapeutics. J Adv Fun Mater. 2020. https:\/\/doi.org\/10.1002\/adfm.202008171.","journal-title":"J Adv Fun Mater"},{"issue":"20","key":"1493_CR27","doi-asserted-by":"publisher","first-page":"23311","DOI":"10.1021\/acsami.0c02785","volume":"12","author":"J Zhou","year":"2020","unstructured":"Zhou J, Han Y, Yang Y, et al. Phospholipid-decorated glycogen nanoparticles for stimuli-responsive drug release and synergetic chemophotothermal therapy of hepatocellular carcinoma. ACS Appl Mater Interfaces. 2020;12(20):23311\u201322.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"23","key":"1493_CR28","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.1021\/acs.jafc.9b02028","volume":"67","author":"X Chen","year":"2019","unstructured":"Chen X, Chen Y, Zou L, et al. Plant-Based nanoparticles prepared from proteins and phospholipids consisting of a core-multilayer-shell structure: fabrication, stability, and foamability. J Agric Food Chem. 2019;67(23):6574\u201384.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"1493_CR29","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.1002\/btm2.10161","volume":"5","author":"Z Gan","year":"2020","unstructured":"Gan Z, Lokugamage MP, Hatit MZC, et al. Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands. Bioeng Transl Med. 2020;5(3):10161.","journal-title":"Bioeng Transl Med"},{"issue":"42","key":"1493_CR30","doi-asserted-by":"publisher","first-page":"28888","DOI":"10.1021\/acsami.6b10360","volume":"8","author":"Z Cao","year":"2016","unstructured":"Cao Z, Zhou X, Wang G. Selective release of hydrophobic and hydrophilic cargos from multi-stimuli-responsive nanogels. ACS Appl Mater Interfaces. 2016;8(42):28888\u201396.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"12","key":"1493_CR31","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.1021\/acs.nanolett.8b03828","volume":"18","author":"H Yang","year":"2018","unstructured":"Yang H, Wang Q, Li Z, et al. Hydrophobicity-adaptive nanogels for programmed anticancer drug delivery. Nano Lett. 2018;18(12):7909\u201318.","journal-title":"Nano Lett"},{"key":"1493_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040718","author":"LI Karpenko","year":"2020","unstructured":"Karpenko LI, Apartsin EK, Dudko SG, et al. Cationic polymers for the delivery of the ebola dna vaccine encoding artificial T-cell immunogen. Vaccines. 2020. https:\/\/doi.org\/10.3390\/vaccines8040718.","journal-title":"Vaccines"},{"issue":"2","key":"1493_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1021\/acsbiomaterials.6b00418","volume":"3","author":"M Zhang","year":"2017","unstructured":"Zhang M, Hong Y, Chen W, et al. Polymers for DNA vaccine delivery. ACS Biomater Sci Eng. 2017;3(2):108\u201325.","journal-title":"ACS Biomater Sci Eng"},{"issue":"8","key":"1493_CR34","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1021\/nl301792g","volume":"12","author":"D Maillard","year":"2012","unstructured":"Maillard D, Kumar SK, Fragneaud B, et al. Mechanical properties of thin glassy polymer films filled with spherical polymer-grafted nanoparticles. Nano Lett. 2012;12(8):3909\u201314.","journal-title":"Nano Lett"},{"issue":"1","key":"1493_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","volume":"9","author":"H He","year":"2019","unstructured":"He H, Lu Y, Qi J, et al. Adapting liposomes for oral drug delivery. Acta Pharm Sin B. 2019;9(1):36\u201348.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"1493_CR36","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.apsb.2021.03.013","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang Q, Qin X, Fang J, et al. Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies. Acta Pharm Sin B. 2021;11(5):1158\u201374.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1493_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.apsb.2018.01.004","volume":"8","author":"T Dai","year":"2018","unstructured":"Dai T, Jiang K, Lu W. Liposomes and lipid disks traverse the BBB and BBTB as intact forms as revealed by two-step Forster resonance energy transfer imaging. Acta Pharm Sin B. 2018;8(2):261\u201371.","journal-title":"Acta Pharm Sin B"},{"key":"1493_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/1475-2875-13-501","volume":"13","author":"A Marijon","year":"2014","unstructured":"Marijon A, Bonnot G, Fourier A, et al. Efficacy of intranasal administration of artesunate in experimental cerebral malaria. Malar J. 2014;13:501.","journal-title":"Malar J"},{"key":"1493_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105632","volume":"157","author":"J Goncalves","year":"2021","unstructured":"Goncalves J, Alves G, Fonseca C, et al. Is intranasal administration an opportunity for direct brain delivery of lacosamide? Eur J Pharm Sci. 2021;157: 105632.","journal-title":"Eur J Pharm Sci"},{"key":"1493_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102114","author":"K Ripandeep","year":"2021","unstructured":"Ripandeep K, Varun G, Guneet S, et al. Intranasal delivery of polymer-anchored lipid nanoconstructs of artemether-lumefantrine in Plasmodium berghei ANKA murine model. J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2020.102114.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"1493_CR41","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1021\/acsinfecdis.0c00124","volume":"6","author":"X Jiang","year":"2020","unstructured":"Jiang X, Chen L, Zheng Z, et al. Synergistic effect of combined artesunate and tetramethylpyrazine in experimental cerebral malaria. ACS Infect Dis. 2020;6(9):2400\u20139.","journal-title":"ACS Infect Dis"},{"key":"1493_CR42","unstructured":"Jiang Xiao Hui, Exploratory study of Artesunate and Tetramethylpyrazine combined therapy for cerebral malaria based on improvement of neurological damage in experimental cerebral malaria. 2019."},{"key":"1493_CR43","doi-asserted-by":"publisher","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 2015;1\u20132:19\u201325.\u00a0https:\/\/doi.org\/10.1016\/j.softx.2015.06.001.","DOI":"10.1016\/j.softx.2015.06.001"},{"issue":"21","key":"1493_CR44","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1039\/C4CC09584G","volume":"51","author":"AA Skjevik","year":"2015","unstructured":"Skjevik AA, Madej BD, Dickson CJ, et al. All-atom lipid bilayer self-assembly with the AMBER and CHARMM lipid force fields. Chem Commun. 2015;51(21):4402\u20135.","journal-title":"Chem Commun"},{"issue":"23","key":"1493_CR45","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1021\/jp101759q","volume":"114","author":"JB Klauda","year":"2010","unstructured":"Klauda JB, Venable RM, Freites JA, et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J Phys Chem B. 2010;114(23):7830\u201343.","journal-title":"J Phys Chem B"},{"issue":"6","key":"1493_CR46","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jcc.21396","volume":"31","author":"D Poger","year":"2010","unstructured":"Poger D, Van Gunsteren WF, Mark AE. A new force field for simulating phosphatidylcholine bilayers. J Comput Chem. 2010;31(6):1117\u201325.","journal-title":"J Comput Chem"},{"key":"1493_CR47","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464209","volume":"98","author":"L Pedersen","year":"1993","unstructured":"Pedersen L. Particle mesh Ewald\u2014An N.Log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089.","journal-title":"J Chem Phys"},{"issue":"12","key":"1493_CR48","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1998","unstructured":"Hess B, Bekker H, Hjc B, et al. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1998;18(12):1463.","journal-title":"J Comput Chem"},{"key":"1493_CR49","doi-asserted-by":"crossref","unstructured":"Lombardo F. C.; Mazzitelli F. D. %J Phys.rev.d, Einstein-langevin equations from running coupling constants. 1996, 55(6), 3889\u20133892.","DOI":"10.1103\/PhysRevD.55.3889"},{"issue":"12","key":"1493_CR50","doi-asserted-by":"publisher","DOI":"10.1063\/1.4978807","volume":"146","author":"Y Lin","year":"2017","unstructured":"Lin Y, Pan D, Li J, et al. Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation. J Cheml Phy. 2017;146(12): 124108.","journal-title":"J Cheml Phy"},{"issue":"42","key":"1493_CR51","doi-asserted-by":"publisher","first-page":"21901","DOI":"10.1039\/D0NR05138A","volume":"12","author":"S Shen","year":"2020","unstructured":"Shen S, Du M, Liu Q, et al. Development of GLUT1-targeting alkyl glucoside-modified dihydroartemisinin liposomes for cancer therapy. Nanoscale. 2020;12(42):21901\u201312.","journal-title":"Nanoscale"},{"issue":"6","key":"1493_CR52","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1021\/acs.nanolett.0c00495","volume":"20","author":"ZJ Chen","year":"2020","unstructured":"Chen ZJ, Yang SC, Liu XL, et al. Nanobowl-supported liposomes improve drug loading and delivery. Nano Lett. 2020;20(6):4177\u201387.","journal-title":"Nano Lett"},{"issue":"11","key":"1493_CR53","first-page":"2728","volume":"46","author":"T Li","year":"2021","unstructured":"Li T, Zhao XL, Shen S, et al. Screening of quantitative preparation quality markers of Yulian Decoction. Zhongguo Zhong Yao Za Zhi. 2021;46(11):2728\u201336.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"12","key":"1493_CR54","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/jcc.21172","volume":"30","author":"WJ Allen","year":"2009","unstructured":"Allen WJ, Lemkul JA, Bevan DR. GridMAT-MD: a grid-based membrane analysis tool for use with molecular dynamics. J Comput Chem. 2009;30(12):1952\u20138.","journal-title":"J Comput Chem"},{"issue":"15","key":"1493_CR55","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.1039\/C5CP07379K","volume":"18","author":"AA Skjevik","year":"2016","unstructured":"Skjevik AA, Madej BD, Dickson CJ, et al. Simulation of lipid bilayer self-assembly using all-atom lipid force fields. Phys Chem Chem Phys. 2016;18(15):10573\u201384.","journal-title":"Phys Chem Chem Phys"},{"key":"1493_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadva.2021.100018","author":"E Jad","year":"2021","unstructured":"Jad E, Alia J, H\u00e9l\u00e8ne G-G, et al. Effect of quercetin on lipid membrane rigidity: assessment by atomic force microscopy and molecular dynamics simulations. BBA Adv. 2021. https:\/\/doi.org\/10.1016\/j.bbadva.2021.100018.","journal-title":"BBA Adv"},{"issue":"7","key":"1493_CR57","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1021\/acs.molpharmaceut.1c00122","volume":"18","author":"M Mahmoudzadeh","year":"2021","unstructured":"Mahmoudzadeh M, Magarkar A, Koivuniemi A, et al. Mechanistic insight into how PEGylation reduces the efficacy of ph-sensitive liposomes from molecular dynamics simulations. Mol Pharm. 2021;18(7):2612\u201321.","journal-title":"Mol Pharm"},{"issue":"3","key":"1493_CR58","first-page":"1639","volume":"16","author":"J Zhu","year":"2018","unstructured":"Zhu J, Zhang W, Wang D, et al. Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate. Exp Ther Med. 2018;16(3):1639\u201346.","journal-title":"Exp Ther Med"},{"issue":"5","key":"1493_CR59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.chom.2014.04.008","volume":"15","author":"H Zhao","year":"2014","unstructured":"Zhao H, Aoshi T, Kawai S, et al. Olfactory plays a key role in spatiotemporal pathogenesis of cerebral malaria. Cell Host Microbe. 2014;15(5):551\u201363.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"1493_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pt.2014.05.002","volume":"30","author":"L Renia","year":"2014","unstructured":"Renia L, Howland SW. Targeting the olfactory bulb during experimental cerebral malaria. Trends Parasitol. 2014;30(8):375\u20136.","journal-title":"Trends Parasitol"},{"issue":"2","key":"1493_CR61","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1148\/radiol.2018181051","volume":"290","author":"A Hoffmann","year":"2019","unstructured":"Hoffmann A, Pfeil J, Mueller AK, et al. MRI of iron oxide nanoparticles and myeloperoxidase activity links inflammation to brain edema in experimental cerebral malaria. Radiology. 2019;290(2):359\u201367.","journal-title":"Radiology"},{"issue":"2","key":"1493_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1046\/j.1365-2125.1998.00655.x","volume":"45","author":"KT Batty","year":"1998","unstructured":"Batty KT, Thu LT, Davis TM, et al. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br J Clin Pharmacol. 1998;45(2):123\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1493_CR63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2006.08.011","volume":"328","author":"F Li","year":"2007","unstructured":"Li F, Feng J, Cheng Q, et al. Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats. Int J Pharm. 2007;328(2):161\u20137.","journal-title":"Int J Pharm"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01493-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:06:56Z","timestamp":1657109216000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01493-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01493-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, all experimental procedures were executed according to the guidelines for care and use of laboratory animals of Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}